Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 13 08 2018
accepted: 25 01 2019
pubmed: 5 2 2019
medline: 16 1 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Cardiogenic shock frequently leads to death even with intensive treatment. Although the leading cause of cardiogenic shock is acute coronary syndrome (ACS), the clinical characteristics and the prognosis of ACS with cardiogenic shock in the present era still remain to be elucidated. We analyzed clinical characteristics and predictors of 30-day mortality in ACS with cardiogenic shock in Japan. The Japanese Circulation Society Cardiovascular Shock registry was a prospective, observational, multicenter, cohort study. Between May 2012 and June 2014, 495 ACS patients with cardiogenic shock were analyzed. The primary endpoint was 30-day all-cause mortality. The median [interquartile range; IQR] age was 71.0 [63.0, 80.0] years. The median [IQR] value of systolic blood pressure (SBP) and heart rate were 75.0 [50.0, 86.5] mm Hg and 65.0 [38.0, 98.0] bpm, respectively. Multivariable analysis showed an odds ratio (OR) of 4.76 (confidence intervals; CI 1.97-11.5, p < 0.001) in the lowest SBP category (< 50 mm Hg) for SBP ≥ 90 mm Hg. Moreover, age per 10 years increase (OR 1.38, CI 1.18-1.61, p = 0.002), deep coma (OR 3.49, CI 1.94-6.34, p < 0.001), congestive heart failure (OR 3.81, CI 2.04-7.59, p < 0.001) and left main trunk disease (LMTD) (OR 2.81, CI 1.55-5.10, p < 0.001) were independent predictors. Severe hypotension, older age, deep coma, congestive heart failure, and LMTD were independent unfavorable factors in ACS complicated by cardiogenic shock in Japan. A prompt assessment of high-risk patients referring to those predictors in emergency room could lead to appropriate treatment without delay.

Identifiants

pubmed: 30715570
doi: 10.1007/s00380-019-01354-9
pii: 10.1007/s00380-019-01354-9
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1241-1249

Références

N Engl J Med. 1999 Aug 26;341(9):625-34
pubmed: 10460813
JAMA. 2001 Jan 10;285(2):190-2
pubmed: 11176812
J Am Coll Cardiol. 2003 Oct 15;42(8):1380-6
pubmed: 14563578
Arch Intern Med. 2003 Oct 27;163(19):2345-53
pubmed: 14581255
Eur Heart J. 2004 Feb;25(4):322-8
pubmed: 14984921
Circulation. 2008 Feb 5;117(5):686-97
pubmed: 18250279
Ann Intern Med. 2008 Nov 4;149(9):618-26
pubmed: 18981487
Am Heart J. 2009 Mar;157(3):569-575.e1
pubmed: 19249431
JACC Cardiovasc Interv. 2009 Jan;2(1):56-64
pubmed: 19463399
N Engl J Med. 2010 Mar 18;362(11):994-1004
pubmed: 20237345
Am Heart J. 2010 Sep;160(3):443-50
pubmed: 20826251
Am Heart J. 2012 Jun;163(6):963-71
pubmed: 22709748
Circulation. 2013 Jan 29;127(4):e362-425
pubmed: 23247304
Circ J. 2014;78(5):1097-103
pubmed: 24662401
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Circulation. 2014 Dec 23;130(25):2354-94
pubmed: 25249586
JACC Cardiovasc Interv. 2014 Dec;7(12):1374-85
pubmed: 25523531
Int J Cardiol. 2015 Apr 15;185:256-62
pubmed: 25814213
Am J Med. 2015 Aug;128(8):852-60
pubmed: 25820165
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
Am J Cardiol. 2015 Jun 1;115(11):1481-6
pubmed: 25840579
Circ Cardiovasc Interv. 2015 Oct;8(10):null
pubmed: 26453685
Circ J. 2016;80(4):852-9
pubmed: 27001192
J Am Coll Cardiol. 2016 Aug 9;68(6):626-635
pubmed: 27491907
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):149-157
pubmed: 27694532
Circ J. 2017 Jan 25;81(2):195-198
pubmed: 27928127
J Am Coll Cardiol. 2017 Apr 18;69(15):1913-1920
pubmed: 28408020
Circ J. 2017 Nov 24;81(12):1766-1767
pubmed: 29129875
N Engl J Med. 2018 Nov 1;379(18):1699-1710
pubmed: 30145971
N Engl J Med. 1971 Dec 23;285(26):1441-6
pubmed: 5122894
Dtsch Med Wochenschr. 1967 Oct 27;92(43):1947-50
pubmed: 5299769
Am J Cardiol. 1967 Oct;20(4):457-64
pubmed: 6059183

Auteurs

Kazuo Sakamoto (K)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiovascular Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Tetsuya Matoba (T)

JCS Shock Registry Scientific Committee, Tokyo, Japan. matoba@cardiol.med.kyushu-u.ac.jp.
Department of Cardiovascular Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. matoba@cardiol.med.kyushu-u.ac.jp.

Masahiro Mohri (M)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan.

Yasushi Ueki (Y)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Emergency and Critical Care Center, Shinshu University School of Medicine, Matsumoto, Japan.

Yasuyuki Tsujita (Y)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Japan.

Masao Yamasaki (M)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiovascular Medicine, NTT Medical Center, Tokyo, Japan.

Nobuhiro Tanaka (N)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan.

Yohei Hokama (Y)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan.

Motoki Fukutomi (M)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.

Katsutaka Hashiba (K)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.

Rei Fukuhara (R)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Satoru Suwa (S)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Japan.

Hirohide Matsuura (H)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.

Eizo Tachibana (E)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Cardiology, Kawaguchi Municipal Medical Center, Kawaguchi, Japan.

Naohiro Yonemoto (N)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Department of Biostatistics, Kyoto University School of Public Health, Kyoto, Japan.

Ken Nagao (K)

JCS Shock Registry Scientific Committee, Tokyo, Japan.
Cardiovascular Center, Nihon University Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH